e-learning
resources
Breathe
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does induction chemotherapy increase operative risk of pneumonectomy?
P. Van Schil
Source:
Breathe 2007; 4: 66
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Van Schil. Does induction chemotherapy increase operative risk of pneumonectomy?. Breathe 2007; 4: 66
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Lung function assessment in octogenarians with lung cancer diagnosis
Home-based telerehabilitation program using real-time monitoring and interactive exercise for patient with lung cancer: A feasibility study
Related content which might interest you:
Can we still justify pneumonectomy following induction chemotherapy?
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006
Persistent N2-disease after induction therapy does not jeopardize outcomes of pneumonectomy
Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery
Year: 2007
Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer
Source: International Congress 2017 – Thoracic surgery
Year: 2017
The effect of neoadjuvant chemoradiotherapy on airway colonization and post operative respiratory complications in the patients undergoing esophagectomy for esophageal cancer
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011
The surgical treatment of lung cancer
Source: Eur Respir Mon; 2009: 44: 187–206
Year: 2009
Thoracoscore fails to predict complications following elective lung resection
Source: Eur Respir J 2012; 40: 1496-1501
Year: 2012
High postoperative risk after pneumonectomy in elderly patients with right-sided lung cancer
Source: Eur Respir J 2002; 19: 141-145
Year: 2002
The effect of resection surgery on long-term treatment outcomes of patients with MDR/XDR-TB
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT).
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Combined and organ-saving operations in patients with advanced lung cancer after induction chemotherapy
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis
Source: Annual Congress 2007 - Controversies in surgical oncology
Year: 2007
Sleeve pneumonectomy for lung cancer – long term survival, operative morbidity and mortality
Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors
Year: 2003
Bronchopleural fistula-risk factors and treatment after lung cancer surgery
Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery
Year: 2007
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Eur Respir J 2009; 34: 17-41
Year: 2009
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection
Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020
Year: 2020
Preoperative physiological data and lung cancer surgery: do the same factors predict post-operative morbidity/mortality and long term survival?
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Physical activity as a predictor of postoperative complications among patients undergoing lung cancer surgery
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Pre-operative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage nonsmall cell lung cancer
Source: Breathe 2010; 7: 196-197
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept